Sinopharm Chuan Kang Pharmaceutical Co., Ltd. is the subsidiary of China national Pharmaceutical Group, Shanghai shyndec Pharmaceutical Co, Ltd. and is acting as the technology incubator of Sichuan Industrial Institute of Antibiotics.
Located in West section of high tech Zone in Chengdu, Sinopharm Chuan Kang Pharmaceutical Co., Ltd covers an area of 50 acres. Many of its workshops, such as solid preparation workshop, liquid preparation workshop, raw materials (fermentation, synthetic) workshop and APIs refining, baking and packaging workshop, have passed GMP certification. The company’s products mainly cover APIs and intermediates, tablets, granules, capsules, soft capsules and oral liquid etc.
Following the concept on a “specialized, refined and characterized” development, the company is dedicated to the production of biological immune inhibitor, Immune enhancer, and anti tumor auxiliary treatment drugs. Among which, the technology of producing tacrolimus, Mycophenolate mofetil, cyclosporine, mannopeptin and ubenimex takes the leading position in China whilst the quality of granisetron hydrochloride and its intermediate product has reached an advanced level in the international market.